Pharmaceuticals manufacturer Arvind Remedies has clocked a 77 per cent growth in net profit for the first quarter at Rs 16 crore, from Rs 9 crore in the previous corresponding quarter. Net sales grew 31 per cent to Rs 184 crore (Rs 140 crore). Arvind B. Shah, Managing Director and Chief Executive Officer, said: “During the quarter, our focus was on branded products in the domestic market and selecting products to file as ANDA (abbreviated new drug application) for the US market.”

comment COMMENT NOW